<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2007-11-4-95-98</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-972</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОГРАММА НЕПРЕРЫВНОГО ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ПО НЕФРОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROGRAM ON CONTINUOUS POSTGRADUATE EDUCATION ON NEPHROLOGY</subject></subj-group></article-categories><title-group><article-title>ТАКРОЛИМУС  В  БАЗОВОЙ  ИММУНОСУПРЕССИИ  ПОСЛЕ  ТРАНСПЛАНТАЦИИ  ПОЧКИ:  ПРАКТИЧЕСКИЕ  РЕКОМЕНДАЦИИ  ПО  ПРИМЕНЕНИЮ</article-title><trans-title-group xml:lang="en"><trans-title>TACROLIMUS  IN  BASE  IMMUNOSUPPRESSION  AFTER  RENAL  TRANSPLANTATION:  REASONS,  DOSING AND  MANAGEMENT</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клим</surname><given-names>Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Kliem</surname><given-names>V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Набоков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nabokov</surname><given-names>A. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Нефрологический  центр  Нижней Саксонии,  Ганновер-Мюнден</institution><country>Germany</country></aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>10</day><month>04</month><year>2007</year></pub-date><volume>11</volume><issue>4</issue><fpage>95</fpage><lpage>98</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Клим Ф., Набоков А.В., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Клим Ф., Набоков А.В.</copyright-holder><copyright-holder xml:lang="en">Kliem V., Nabokov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/972">https://journal.nephrolog.ru/jour/article/view/972</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>такролимус</kwd><kwd>трансплантация почки</kwd><kwd>показания к конверсии</kwd><kwd>дозировка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tacrolimus</kwd><kwd>kidney transplantation</kwd><kwd>reasons for conversion</kwd><kwd>dosing</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mayer AD, Dimitrewski J, Squifflet J-P et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 1997; 64: 436-443</mixed-citation><mixed-citation xml:lang="en">Mayer AD, Dimitrewski J, Squifflet J-P et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 1997; 64: 436-443</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pirsch JD, Miller J, Deierhoi MH et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-983</mixed-citation><mixed-citation xml:lang="en">Pirsch JD, Miller J, Deierhoi MH et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-983</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Клим Ф. Такролимус при трансплантации почки. Обзор, часть I. Нефрология 2007; 11(2): 7-25</mixed-citation><mixed-citation xml:lang="en">Клим Ф. Такролимус при трансплантации почки. Обзор, часть I. Нефрология 2007; 11(2): 7-25</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Клим Ф. Такролимус при трансплантации почки. Обзор, часть II. Нефрология 2007; 11 (в печати)</mixed-citation><mixed-citation xml:lang="en">Клим Ф. Такролимус при трансплантации почки. Обзор, часть II. Нефрология 2007; 11 (в печати)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jordan ML, Naraghi R, Shapiro R et al. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc 1998; 30: 1257-1260</mixed-citation><mixed-citation xml:lang="en">Jordan ML, Naraghi R, Shapiro R et al. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc 1998; 30: 1257-1260</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kliem V, Rademacher J, Hiss M et al. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation. Transplant Proc 1999; 31 [Suppl 7A]: 37S-40S</mixed-citation><mixed-citation xml:lang="en">Kliem V, Rademacher J, Hiss M et al. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation. Transplant Proc 1999; 31 [Suppl 7A]: 37S-40S</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Burrows L, Knight R, Genyk Y et al. Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients. Transplant Proc 1998; 30: 2030-2032</mixed-citation><mixed-citation xml:lang="en">Burrows L, Knight R, Genyk Y et al. Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients. Transplant Proc 1998; 30: 2030-2032</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Friemann S, Stopp K, Christ B et al. Conversion to tacrolimus in hyperlipidemic patients. Transplant Proc 1999; 31[Suppl 7A]: 41S-43S</mixed-citation><mixed-citation xml:lang="en">Friemann S, Stopp K, Christ B et al. Conversion to tacrolimus in hyperlipidemic patients. Transplant Proc 1999; 31[Suppl 7A]: 41S-43S</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Arns W, Merkel F, Paul A. Umstellung auf Basis-Immunsuppression mit Tacrolimus bei akuter und chronischer Abstossung sowie Ciclosporin-Toxizitaet. In: Binswanger U, Heemann U, Margreiter R, Ringe B, Herausgeber. Tacrolimus in der Nierentransplantation. Lengerich, Pabst Science Publishers, 1999; 91-99</mixed-citation><mixed-citation xml:lang="en">Arns W, Merkel F, Paul A. Umstellung auf Basis-Immunsuppression mit Tacrolimus bei akuter und chronischer Abstossung sowie Ciclosporin-Toxizitaet. In: Binswanger U, Heemann U, Margreiter R, Ringe B, Herausgeber. Tacrolimus in der Nierentransplantation. Lengerich, Pabst Science Publishers, 1999; 91-99</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Meier M, Nitschke M, Weidtmann B et al. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. Transplantation 2006; 81: 1035-1040</mixed-citation><mixed-citation xml:lang="en">Meier M, Nitschke M, Weidtmann B et al. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. Transplantation 2006; 81: 1035-1040</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
